bretylium has been researched along with Syndrome in 1 studies
bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapoor, JR | 1 |
| Batsford, WP | 1 |
| Foody, JM | 1 |
1 other study available for bretylium and Syndrome
| Article | Year |
|---|---|
Refractory Electrical Storm suppression by bretylium.
Topics: Adult; Anti-Arrhythmia Agents; Bretylium Compounds; Heart Ventricles; Humans; Male; Recurrence; Synd | 2006 |